InsidersTradesSigma
Follow the 삼성제약 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼성제약 has published 2 insider filings. Market capitalisation: €111.1bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: 삼성제약. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samsung Pharmaceutical是一家韩国公司，专注于医疗保健和制药领域。该公司在韩国交易所上市。